Detalhe da pesquisa
1.
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
N Engl J Med
; 355(26): 2733-43, 2006 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17192538
2.
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.
Breast Cancer Res Treat
; 112(3): 533-43, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18188694